Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (231-240 of 308) with videos related to

Pageof 31
Sort By:
Archives of Internal Medicine|September 12, 2007
The variability and quality of medication container labelsWilliam H Shrank, Jessica Agnew-Blais, Niteesh K Choudhry, et al.
Health Services Research|September 25, 2012
Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarctionKouta Ito, William H Shrank, Jerry Avorn, et al.
Arthritis and Rheumatism|May 29, 2007
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritisSebastian Schneeweiss, Soko Setoguchi, Michael E Weinblatt, et al.
Journal of Health Politics, Policy and Law|July 22, 2022
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature ReviewBeatrice L Brown, Mayookha Mitra-Majumdar, Krysten Joyce, et al.
Drug Safety|October 9, 2009
Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysisWinfried Rief, Yvonne Nestoriuc, Anna von Lilienfeld-Toal, et al.
Annals of Internal Medicine|March 17, 2015
Cost-effectiveness of novel regimens for the treatment of hepatitis C virusMehdi Najafzadeh, Karin Andersson, William H Shrank, et al.
Journal of Clinical Epidemiology|January 26, 2002
Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapyDaniel H Solomon, David A Ganz, Jerry Avorn, et al.
Medical Care|October 25, 2007
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsSebastian Schneeweiss, Amanda R Patrick, Til Stürmer, et al.
Journal of the American Society of Nephrology : JASN|April 4, 2008
The effect of altitude on dosing and response to erythropoietin in ESRDM Alan Brookhart, Sebastian Schneeweiss, Jerry Avorn, et al.
Archives of Internal Medicine|May 11, 2011
The implications of therapeutic complexity on adherence to cardiovascular medicationsNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
Pageof 31

Showing results (231-240 of 308) with videos related to

Sort By:
Pageof 31
Archives of Internal Medicine|September 12, 2007
The variability and quality of medication container labelsWilliam H Shrank, Jessica Agnew-Blais, Niteesh K Choudhry, et al.
Health Services Research|September 25, 2012
Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarctionKouta Ito, William H Shrank, Jerry Avorn, et al.
Arthritis and Rheumatism|May 29, 2007
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritisSebastian Schneeweiss, Soko Setoguchi, Michael E Weinblatt, et al.
Journal of Health Politics, Policy and Law|July 22, 2022
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature ReviewBeatrice L Brown, Mayookha Mitra-Majumdar, Krysten Joyce, et al.
Drug Safety|October 9, 2009
Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysisWinfried Rief, Yvonne Nestoriuc, Anna von Lilienfeld-Toal, et al.
Annals of Internal Medicine|March 17, 2015
Cost-effectiveness of novel regimens for the treatment of hepatitis C virusMehdi Najafzadeh, Karin Andersson, William H Shrank, et al.
Journal of Clinical Epidemiology|January 26, 2002
Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapyDaniel H Solomon, David A Ganz, Jerry Avorn, et al.
Medical Care|October 25, 2007
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsSebastian Schneeweiss, Amanda R Patrick, Til Stürmer, et al.
Journal of the American Society of Nephrology : JASN|April 4, 2008
The effect of altitude on dosing and response to erythropoietin in ESRDM Alan Brookhart, Sebastian Schneeweiss, Jerry Avorn, et al.
Archives of Internal Medicine|May 11, 2011
The implications of therapeutic complexity on adherence to cardiovascular medicationsNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
Pageof 31